Poland· PL-100504795

Nilotinib Accord

A nilotinib product containing nilotinibum, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 14 of our 19 countries.

ATC L01EA03

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nilotinibumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Nilotinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EA03 (nilotinib), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search nilotinib products by name

Nilotinib · ATC L01EA03

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nilotinib costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Nilotinib · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

CH Switzerland$56.31

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Nilotinibum
Manufacturer: Accord Healthcare S.L.U.
Country: Poland (PL)
ATC code: L01EA03
ATC class: Nilotinib
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

gtin
05055565796061

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

756 interactions on record for nilotinib.

Graded by severity as the source publishes them — 303 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nilotinib against other medicines How interaction checks work

Nilotinib · interactions on record

756 records

303 severe
433 moderate
20 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nilotinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nilotinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Nilotinib Stada, Nilotinib Teva
Belgium · Nilotinb Eg, Nilotinib
Bulgaria · Нилотиниб Зентива, Нилотиниб Стада
Cyprus · Nilotinib Bioars, Nilotinib Olpha
Czechia · Nilotinib, Nilotinib Stada
Germany · Nilotinib Al, Nilotinib Al 150 Mg Hartkapseln Al
Denmark · Nilotinib "olpha", Nilotinib Stada
Estonia · Nilotinib Olpha, Nilotinib Stada
Spain · Nilotinib Cipla, Nilotinib Eugia
Finland · Nilotinib Stada, Nilotinib Zentiva
France · Nilotinib Arrow, Nilotinib Biogaran
United Kingdom (Northern Ireland) · Nilotinib Amarox, Nilotinib Teva Uk
Greece · Lobynia, Nilotinib Anabiosis
Croatia · Nilmat, Nilotinib Devatis
Hungary · Krufton, Nilotinib
Ireland · Nilotinib Clonmel
Iceland · Nilotinib, Nilotinib Accord
Italy · Nilotinib Cipla, Nilotinib Eg
Liechtenstein · Nilotinib Accord, Tasigna
Lithuania · Krufton, Nilotinib Olpha
Luxembourg · Nilotinib Eg, Nilotinib Eugia
Latvia · Krufton, Nilotinib Olpha
Malta · Nilotinib Hydrochloride Dihydrate Clonmel, Nilotinib Olpha
Netherlands · Nilotinib Cf, Nilotinib Cipla
Norway · Nilotinib Accord, Nilotinib Cipla
Portugal · Nilotinib Eugia, Nilotinib Generis
Romania · Krufton, Nilotinib Cipla
Sweden · Nilotinib Cipla, Nilotinib Devatis
Slovenia · Nilmat, Nilotinib Stada
Slovakia · Krufton, Nilotinib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/12b0ef79-827f-4bdb-80aa-da5b1915f685
GET /v1/drugs/12b0ef79-827f-4bdb-80aa-da5b1915f685?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "Rpz ¦ EU/1/24/1845/018 ¦ 157859\n40 kaps. w blistrze perforowanym\nRpz ¦ EU/1/24/1845/024 ¦ 157860\n392 kaps. w blistrze perforowanym\nRpz ¦ EU/1/24/1845/016 ¦ 157861\n28 kaps. w blistrze perforwanym\nRpz ¦ EU/1/24/1845/023 ¦ 157862\n120 kaps. w blistrze perforowanym\nRpz ¦ EU/1/24/1845/020 ¦ 157863\n120 kaps.\n05055565796061 ¦ Rpz ¦ EU/1/24/1845/019 ¦ 157864\n112 kaps.\nRpz ¦ EU/1/24/1845/017 ¦ 157865\n40 kaps.\nRpz ¦ EU/1/24/1845/021 ¦ 157866\n392 kaps.\nRpz ¦ EU/1/24/1845/015 ¦ 157867\n28 kaps.\nRpz ¦ EU/1/24/1845/022 ¦ 157868\n112 kaps. w blistrze perforowanym",
  "substance": "Nilotinibum 200 mg",
  "common_name": "Nilotinibum",
  "pl_product_id": "100504795",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

API reference MCP server Plans

See everything about nilotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console